Intellia Therapeutics, Inc., based in CAMBRIDGE, Mass., recently announced that they will be hosting a conference call on August 8, 2024, at 8 a.m. ET to discuss their financial results and operational highlights for the second quarter of 2024. This leading clinical-stage gene editing company, known for its focus on revolutionizing medicine with CRISPR-based therapies, invites both U.S. and international callers to join the call by dialing 1-833-316-0545 and 1-412-317-5726, respectively, approximately five minutes before the scheduled start time. Participants should request to be connected to the Intellia Therapeutics conference call. Additionally, a live webcast of the call will be available for those who prefer to join online.
For those unable to participate in the live call, a replay will be accessible through the Events and Presentations page of the Investors & Media section on Intellia’s website at www.intelliatx.com starting at 12 p.m. ET on August 8, 2024.
Intellia Therapeutics, Inc. is recognized for its commitment to utilizing CRISPR technology to facilitate precise gene editing within the human body for the treatment of various diseases. Through their innovative in vivo and ex vivo programs, Intellia aims to address conditions such as cancer and autoimmune diseases by editing genes directly within the body or engineering human cells externally.
With a team of experts and a wealth of scientific knowledge, Intellia is dedicated to advancing the field of gene editing and shaping the future of medicine. By continuously enhancing their CRISPR-based platform with cutting-edge editing and delivery techniques, the company remains at the forefront of medical innovation.
Investors interested in learning more about Intellia Therapeutics can contact Ian Karp, Senior Vice President of Investor Relations and Corporate Communications, at ian.karp@intelliatx.com, or Lina Li, Senior Director of Investor Relations and Corporate Communications, at lina.li@intelliatx.com. Additional information about the company and its mission can be found on their website at intelliatx.com, or by following them on Twitter @intelliatx.
